Human placenta expresses both peripheral and neuronal isoform of tryptophan hydroxylase.

Biochimie

INRS-Institut Armand-Frappier, Laval, QC, Canada; BioMed Research Centre, Laval, QC, Canada; Center for Interdisciplinary Research on Well-Being, Health, Society and Environment, Université du Québec à Montréal, Montréal, QC, Canada. Electronic address:

Published: September 2017

AI Article Synopsis

  • The study investigates the role of serotonin in human placental development, focusing on the synthesis of serotonin by specific cell types within the placenta.
  • Researchers found that both tryptophan hydroxylase isoforms (TPH1 and TPH2), essential for serotonin production, are expressed in various placental cells throughout pregnancy.
  • The findings highlight the importance of the placental serotonin system for healthy pregnancy and fetal development, suggesting a need for further research on its regulation and potential disruptions.

Article Abstract

The role of placental serotonin has been an active topic of research notably because of its crucial role in brain development. However, which cell types synthesize serotonin in human placenta remains unknown. Moreover, it is not known if the two tryptophan hydroxylase isoforms (TPH1 and TPH2), the rate-limiting enzymes in serotonin biosynthesis, are expressed in placenta. Human placentas were obtained in first trimester or at term, and trophoblast cells were isolated and purified using a magnetic cell sorter and placed in primary culture. The tissue sublocalization of each TPH was determined by immunohistochemistry. TPH expression in primary villous trophoblasts was determined by PCR and immunoblotting, and serotonin secretion by LC-MS/MS. Villous cytotrophoblasts, syncytiotrophoblast, fetal capillaries, extravillous cytotrophoblasts, and decidual cells co-expressed TPH1 and TPH2. Moreover, mRNA and protein levels of both TPHs were detected in human primary trophoblast as well as in mouse placental tissues. Finally, human trophoblast cells were shown to produce serotonin de novo. This study demonstrates that both TPH1 and TPH2 are expressed in human and mouse placenta throughout pregnancy and helps to better understand the placental serotonin system, which is crucial for healthy pregnancy and fetal development. It is therefore important to further understand regulation of the placental serotonin system and how its disruption during pregnancy may impact the developing fetus and subsequent child programming.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biochi.2017.07.008DOI Listing

Publication Analysis

Top Keywords

placental serotonin
12
tph1 tph2
12
human placenta
8
tryptophan hydroxylase
8
trophoblast cells
8
serotonin system
8
serotonin
7
human
6
placenta expresses
4
expresses peripheral
4

Similar Publications

Article Synopsis
  • Rapid correction of chronic hyponatremia can lead to osmotic demyelination syndrome (ODS), especially in patients with underlying conditions like Sheehan’s syndrome, a rare pituitary disorder following severe postpartum hemorrhage.
  • A case report details a 40-year-old woman who experienced neurological decline due to the correction of her long-standing hyponatremia, which had been mismanaged for years, leading to extrapontine and then central pontine myelinolysis.
  • The case emphasizes that even gradual correction of low sodium levels poses risks and highlights the need for careful management in patients with chronic hyponatremia and related conditions.
View Article and Find Full Text PDF

The high prevalence of major depressive disorder (MDD) among women of childbearing age necessitates careful consideration of antidepressant use during pregnancy. Although newer antidepressants, such as Vilazodone (VLZ), are preferred for their enhanced therapeutic profiles; however, their safety during pregnancy and long-term effects on offspring brains remain inadequately addressed. Therefore, this study aimed to investigate the reproductive and developmental neurotoxicity of VLZ given at equivalent therapeutic doses during gestation in a rat model.

View Article and Find Full Text PDF

Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression.

Int J Mol Sci

October 2024

Center for Neural Repair and Rehabilitation (Shriners Hospitals Pediatric Research Center), Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.

Article Synopsis
  • * A study compared placentas from pregnant women who used opioids or alcohol with control samples to analyze SERT expression using quantitative western blot techniques.
  • * Opioid exposure resulted in unique SERT modifications and new fragments, while alcohol exposure led to lower overall SERT levels, suggesting that these changes may affect fetal brain development and neurotransmission.
View Article and Find Full Text PDF

Sertraline-induced 5-HT dysregulation in mouse cardiomyocytes and the impact on calcium handling.

Am J Physiol Heart Circ Physiol

December 2024

Division of Pediatric Critical Care, Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States.

Selective serotonin reuptake inhibitors (SSRIs) are prescribed in 15% of pregnancies in the United States for depression. Maternal use of SSRIs has been linked to an increased risk of congenital heart defects, but the exact mechanism of pathogenesis is unknown. SSRIs, including sertraline, are permeable to the placenta and can produce direct fetal exposure.

View Article and Find Full Text PDF

GDF15 Targeting for Treatment of Hyperemesis Gravidarum.

Medicines (Basel)

August 2024

Department of Chemistry and Physics, Southern Utah University, Cedar City, UT 84720, USA.

Nausea and vomiting during pregnancy (NVP), particularly its severe form, Hyperemesis gravidarum (HG), affects up to 70% of pregnancies and significantly impacts the quality of life for those with the condition as well as generates a great economic burden, with annual costs exceeding $1.7 billion in the United States. Despite the available treatments targeting neurotransmitters like serotonin and dopamine, many patients experience inadequate relief and suffer from severe side effects, including headaches and dizziness.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!